The Supreme Court will consider a challenge brought forth by safety net hospitals. A Trump-era ruling leading to reduced drug costs under Medicare will be considered and could lead to widespread consequences for the Biden administration.
“The decision could create a headache for the Biden administration, as its rule determining pay rates for discounted drugs is under White House review. Department of Health and Human Services Secretary Xavier Becerra has already had to backtrack in attempts to mediate a separate conflict between drugmakers and hospitals over the same drug discount program.” Read more here.
(Source: Rachel Cohrs, STAT News, 7/2/21)